Where Policy Meets Practice in Clinical Research

September 16, 2026—This live webinar explores how policy decisions and regulatory priorities influence clinical trial operations, site workflows, technology adoption, and participant access. Through a discussion of both the broader policy landscape and real-world operational impact, speakers will examine how clinical research professionals can better understand policy shifts, anticipate downstream effects, and engage more thoughtfully in conversations that shape the future of clinical trials.

2026 ACRP and Academy Annual Membership Meeting

October 14, 2026—Join us as ACRP Leadership shares how we’ve worked to advance the clinical research profession over the past year. We’ll share a full picture of where we’ve been, highlight our 50th Anniversary year, and share what’s ahead for 2027.

AI in Action: Shaping the Future of Oncology Clinical Research

November 18, 2026—This live webinar explores practical applications of AI in oncology trials, focusing on three high-impact areas: 1) patient matching and identification using advanced algorithms to accelerate enrollment and improve diversity; 2) seamless data collection through integration from electronic medical records to electronic data capture, reducing manual errors and increasing efficiency; and 3) automated imaging analysis, such as AI-driven RECIST measurements, to improve consistency and speed in response assessments.

​​Trial Feasibility and Selection Under ICH E6(R3) Guidance​

This course provides a practical framework for assessing trial feasibility and selecting trials that align with your site’s capabilities, patient population, and strategic goals. Applying ICH GCP E6(R3) principles to site-level feasibility decisions, you will learn how to use historical trial performance data, current patient population data, and the four key feasibility elements, interest, accruability, capacity, and trial portfolio alignment, to evaluate protocols, identify potential risks, support participant-focused trial conduct, and make informed, defensible trial selection decisions.

​​Investigator Responsibilities Under ICH E6(R3) Guidance​

This 90-minute course explores investigator responsibilities through the lens of ICH E6(R3), with supporting references to applicable FDA regulations and related ICH guidance. Through practical examples and real-world scenarios, you’ll examine expectations for investigator oversight, accountability for delegated activities, and the responsibilities that remain with investigators throughout the trial lifecycle.